TY - JOUR
T1 - Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products
T2 - Is It the Dawning of a New Era?
AU - Chan, Yau Tuen
AU - Wang, Ning
AU - Tan, Hor Yue
AU - Li, Sha
AU - Feng, Yibin
N1 - Funding Information:
This study was supported by the Research Grant Council, the HKSAR (Project code: RGC GRF 17152116, 17121419), the Commissioner for Innovation Technology, the HKSAR (Project code: ITS/091/16FX), and the Health and Medical Research Fund (HMRF) (Project code: 16172751).
Publisher Copyright:
© 2020 Chan, Wang, Tan, Li and Feng.
PY - 2020/4/30
Y1 - 2020/4/30
N2 - Liver fibrosis is a progressive liver damage condition that is worth studying widely. It is important to target and alleviate the disease at an early stage before turning into later cirrhosis or liver cancer. There are currently no direct medicines targeting the attenuation or reversal of liver fibrosis, and so there is an urgent need to look into this area. Traditional Chinese Medicine has a long history in using herbal medicines to treat liver diseases including fibrosis. It is time to integrate the ancient wisdom with modern science and technology to look for the best solution to the disease. In this review, the principal concept of the pathology of liver fibrosis will be described, and then some of the single compounds isolated from herbal medicines, including salvianolic acids, oxymatrine, curcumin, tetrandrine, etc. will be discussed from their effects to the molecular mechanism behind. Molecular targets of the compounds are analyzed by network pharmacology approach, and TGFβ/SMAD was identified as the most common pathway. This review serves to summarize the current findings of herbal medicines combining with modern medicines in the area of fibrosis. It hopefully provides insights in further pharmaceutical research directions.
AB - Liver fibrosis is a progressive liver damage condition that is worth studying widely. It is important to target and alleviate the disease at an early stage before turning into later cirrhosis or liver cancer. There are currently no direct medicines targeting the attenuation or reversal of liver fibrosis, and so there is an urgent need to look into this area. Traditional Chinese Medicine has a long history in using herbal medicines to treat liver diseases including fibrosis. It is time to integrate the ancient wisdom with modern science and technology to look for the best solution to the disease. In this review, the principal concept of the pathology of liver fibrosis will be described, and then some of the single compounds isolated from herbal medicines, including salvianolic acids, oxymatrine, curcumin, tetrandrine, etc. will be discussed from their effects to the molecular mechanism behind. Molecular targets of the compounds are analyzed by network pharmacology approach, and TGFβ/SMAD was identified as the most common pathway. This review serves to summarize the current findings of herbal medicines combining with modern medicines in the area of fibrosis. It hopefully provides insights in further pharmaceutical research directions.
KW - cirrhosis
KW - hepatic stellate cells
KW - herbal medicine
KW - liver fibrosis
KW - natural product
KW - network pharmacology
UR - http://www.scopus.com/inward/record.url?scp=85084760490&partnerID=8YFLogxK
U2 - 10.3389/fphar.2020.00548
DO - 10.3389/fphar.2020.00548
M3 - Review article
AN - SCOPUS:85084760490
SN - 1663-9812
VL - 11
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 548
ER -